In an increasingly digital world, access to digital money has ramifications for physical health. New research from Aaron Klein explores the inequalities around access to and cost of digital money, and how it could translate to—or even exacerbate—inequalities in public health.
Interest rates on government debt have been falling in many countries for decades. Alan Auerbach and William Gale examine the implications of sustained low interest rates for the structure of tax policy.
Some are concerned that if drug price reductions for Medicare are included in the upcoming reconciliation bill it will lead to “cost-shifting,” i.e. higher prices for payers on the commercial market. Loren Adler explains why that is unlikely.
A brief proposal to expand the scope of whistleblower programs. Enforcement actions from the Securities and Exchange Commission’s whistleblower program have resulted in billions of dollars in recovered financial sanctions. Martin Totaro and Connor Raso propose that similar programs be enacted at other federal agencies.
Changes in emergency physician service prices after Connecticut’s 2016 surprise billing law. Once the No Surprises Act takes effect in 2022, states that previously enacted similar laws will have to choose between modifying their own laws or adopting federal protection. One such state law is the subject of this new report from the USC-Brookings Schaeffer Initiative on Health Policy.
Due to the COVID-19 pandemic, the Brookings Institution campus in Washington, D.C. is currently closed and all events are virtual only. For more information on the Institution's response, read our full guidance here.
The Brookings Institution, 1775 Massachusetts Ave NW, Washington, DC 20036
